Authors:
SARIHAN S
DARENDELILER E
KIZIR A
TUNCEL N
ORAL EN
KARADENIZ A
BILGE N
Citation: S. Sarihan et al., A PHASE-II TRIAL, FEASIBILITY OF COMBINATION OF DAILY CISPLATINUM ANDACCELERATED RADIOTHERAPY VIA CONCOMITANT BOOST IN STAGE-III NONSMALL CELL LUNG-CANCER, Lung cancer, 20(1), 1998, pp. 37-46
Authors:
YASASEVER V
DINCER M
CAMLYCA H
KARALOOLU D
KIZIR A
TOPUZ E
DALAY N
Citation: V. Yasasever et al., CYFRA-21-1 IS THE MOST SENSITIVE TUMOR-MARKER IN NONSMALL CELL LUNG-CANCER, Journal of tumor marker oncology, 12(2), 1997, pp. 135-140
Authors:
KURUL S
DINCER M
KIZIR A
UZUNISMAIL A
DARENDELILER E
Citation: S. Kurul et al., PLASTIC-SURGERY IN IRRADIATED AREAS - ANALYSIS OF 200 CONSECUTIVE CASES, European journal of surgical oncology, 23(1), 1997, pp. 48-53
Authors:
YASASEVER V
KARALOGLU D
KIZIR A
CAMLICA H
DALAY N
Citation: V. Yasasever et al., EVALUATION OF SERUM TUMOR-MARKERS IN GASTROINTESTINAL-TRACT TUMORS, Journal of tumor marker oncology, 11(3), 1996, pp. 29-33
Citation: D. Karaloglu et al., SERUM LEVELS OF MUTANT P53 PROTEIN IN CANCER, Journal of experimental & clinical cancer research, 15(4), 1996, pp. 335-339